Related Experiment Videos
Clinical experience with a new transvenous atrial lead
Chest
|February 1, 1978
Summary
A new atrial lead offers promising results for permanent pacemaker systems, addressing a key barrier to atrial pacing. This development could improve patient care by enabling more widespread use of atrial pacing technology.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Medical Devices
Background:
- Atrial pacing systems offer clinical benefits but are underutilized (<1% of permanent pacemakers).
- A primary limitation is the lack of clinically successful and easily positioned atrial leads.
Purpose of the Study:
- To evaluate the performance and safety of a newly developed permanent transvenous atrial lead.
Main Methods:
- The study involved 28 patients implanted with the new atrial lead over 16 months.
- Acute pacing thresholds and atrial electrogram amplitudes were measured.
- Lead stability and sensing/pacing function were monitored post-implantation.
Main Results:
- Low acute voltage thresholds (average 1.1 V at 1 msec pulse width) and high atrial electrogram amplitudes (average 5.1 mV) were observed.
- Intermittent sensing failures occurred in three patients post-implantation.
- Two cases of lead dislodgement were managed successfully with repositioning or observation, with no further complications.
Conclusions:
- The new transvenous atrial lead demonstrates promising performance and acceptable stability.
- This lead addresses a critical need, potentially increasing the adoption of atrial pacing systems.